not tagged
not tagged
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
benefit in female patients? second crc trial in 2 days with negative primary endpoint (pfs/dfs) but positive os different. 62% completion rate of pre-op chemo seems low. and are we overtreating in the post-idea era? and dmmr? #asco22 
Gastrointestinal medical oncology, cancer of unknown primary, and value-based cancer care delivery. Tweets mine.